Clemastine: Clinical Trials

1 trial of Clemastine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Clemastine: new trials by email Literature Review of Clemastine trials Research Report on Clemastine

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis
Clemastine Fumarate, Placebo - Multiple Sclerosis, Internuclear Ophthalmoplegia
Phase 3TerminatedAmsterdam UMC, location VUmc472022-08-302026-05-06

Conditions studied

Multiple Sclerosis (1)  ·  Ocular Motility Disorders (1)

Sponsors

Amsterdam UMC, location VUmc (1)

Countries

Netherlands (1)

Top investigators

Axel Petzold, Dr. (1)

Results publications

PMID 38296293